Biotest Aktiengesellschaft (HAM:BIO)
Germany · Delayed Price · Currency is EUR 41.20
-2.20 (-5.07%)
At close: Jul 15, 2025
HAM:BIO Revenue
Biotest Aktiengesellschaft had revenue of 124.20M EUR in the quarter ending March 31, 2025, a decrease of -42.29%. This brings the company's revenue in the last twelve months to 635.20M, down -18.83% year-over-year. In the year 2024, Biotest Aktiengesellschaft had annual revenue of 726.20M with 6.08% growth.
Revenue (ttm)
635.20M
Revenue Growth
-18.83%
P/S Ratio
2.20
Revenue / Employee
254.59K
Employees
2,495
Market Cap
1.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 726.20M | 41.60M | 6.08% |
| Dec 31, 2023 | 684.60M | 168.50M | 32.65% |
| Dec 31, 2022 | 516.10M | 500.00K | 0.10% |
| Dec 31, 2021 | 515.60M | 31.40M | 6.48% |
| Dec 31, 2020 | 484.20M | 65.10M | 15.53% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.15B |
| Siemens Aktiengesellschaft | 77.82B |
| Deutsche Telekom AG | 120.25B |
| Allianz SE | 109.03B |
| Rheinmetall AG | 10.48B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
| Siemens Energy AG | 37.44B |
| Siemens Healthineers AG | 23.14B |
Biotest Aktiengesellschaft News
- 14 days ago - EQS-News: Biotest AG: Annual General Meeting approves dividend distribution - Wallstreet:Online
- 23 days ago - EQS-News: Biotests’ positive fibrinogen phase III trial results published in The Lancet’s eClinicalMedicine - Wallstreet:Online